ProPhase Labs, Inc. Announces Closing of Public Offering
January 21, 2021 16:30 ET | Source: ProPhase Labs, Inc. ProPhase Labs, Inc. DOYLESTOWN, Pennsylvania, UNITED STATES
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced public offering of 3,000,000 shares of its common stock at a public offering price of $12.50 per share, for gross proceeds of $37,500,000, before deducting underwriting discounts and commissions and offering expenses. In addition, ProPhase Labs, Inc. has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions.